Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
McKesson
Teva
Fish and Richardson
Citi
Novartis
UBS
Queensland Health
Chinese Patent Office
Johnson and Johnson

Generated: February 21, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,444,784

« Back to Dashboard

Summary for Patent: 4,444,784
Title: Antihypercholesterolemic compounds
Abstract:6(R)-[2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)-polyhydronaphthyl-1')-ethyl]-4 (R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones are prepared by acylation of the corresponding 8'-hydroxy compounds. The products are strong inhibitors of the biosynthesis of cholesterol.
Inventor(s): Hoffman; William F. (Lansdale, PA), Smith; Robert L. (Lansdale, PA), Willard; Alvin K. (DE)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:06/217,640
Patent Claims: 1. A compound of the formula: ##STR68## wherein R' is H or CH.sub.3 ; R is

(1) 1,1-dimethylpropyl,

(2) C.sub.3-10 cycloalkyl,

(3) C.sub.2-10 alkenyl,

(4) C.sub.1-10 CF.sub.3 -substituted alkyl,

(5) phenyl,

(6) halophenyl,

(7) phenyl-C.sub.1-3 alkyl,

(8) substituted phenyl-C.sub.1-3 alkyl in which the substituent is halo, C.sub.1-3 alkyl or C.sub.1-3 alkoxy;

the dotted lines at X, Y and Z represent possible double bonds, said double bonds, when any are present, being either X and Z in combination or X, Y or Z alone; or the corresponding dihydroxy acid of the formula: ##STR69## or a pharmaceutically acceptable salt of said acid, a C.sub.1-4 alkyl ester of said acid or a phenyl-, dimethylamino-, or acetylamino-substituted-C.sub.1-4 alkyl ester of said acid.

2. The compound of claim 1 wherein R' is CH.sub.3.

3. The compound of claim 1 wherein R is 1,1-dimethylpropyl.

4. The compound of claim 2 wherein R is 1,1-dimethylpropyl.

5. The compound of claim 1 wherein none of X, Y or Z is a double bond.

6. A pharmaceutical antihypercholesterolemic composition comprising a pharmaceutical carrier and an antihypercholesterolemic effective amount of a compound of structural formula: ##STR70## in which R' is H or CH.sub.3 ; R is

(1) 1,1-dimethylpropyl,

(2) C.sub.3-10 cycloalkyl,

(3) C.sub.2-10 alkenyl,

(4) C.sub.1-10 CF.sub.3 -substituted alkyl,

(5) phenyl,

(6) halophenyl,

(7) phenyl-C.sub.1-3 alkyl,

(8) substituted phenyl-C.sub.1-3 alkyl in which the substituent is halo, C.sub.1-3 alkyl or C.sub.1-3 alkoxy;

the dotted lines at X, Y and Z represent possible double bonds, said double bonds, when any are present, being either X and Z in combination or X, Y or Z alone; or

the corresponding dihydroxy acid of the formula: ##STR71## or a pharmaceutically acceptable salt of said acid, a C.sub.1-4 alkyl ester of said acid or a phenyl-, dimethylamino-, or acetylamino-substituted-C.sub.1-4 alkyl ester of said acid.

7. The composition of claim 6 wherein R' is CH.sub.3.

8. The composition of claim 6 wherein R is 1,1-dimethylpropyl.

9. The composition of claim 7 wherein R is 1,1-dimethylpropyl.

10. The composition of claim 6 wherein none of X, Y or Z is a double bond.

11. A method of treating hypercholesterolemia in a patient in need of such treatment which comprises administration of an antihypercholesterolemic effective amount of a compound of structural formula: ##STR72## in which R' is H or CH.sub.3 ; R is

(1) 1,1-dimethylpropyl,

(2) C.sub.3-10 cycloalkyl,

(3) C.sub.2-10 alkenyl,

(4) C.sub.1-10 CF.sub.3 -substituted alkyl,

(5) phenyl,

(6) halophenyl,

(7) phenyl-C.sub.1-3 alkyl,

(8) substituted phenyl-C.sub.1-3 alkyl in which the substituent is halo, C.sub.1-3 alkyl or C.sub.1-3 alkoxy;

the dotted lines at X, Y and Z represent possible double bonds, said double bonds, when any are present, being either X and Z in combination or X, Y or Z alone; or

the corresponding dihydroxy acid of the formula: ##STR73## or a pharmaceutically acceptable salt of said acid, a C.sub.1-4 alkyl ester of said acid or a phenyl-, dimethylamino-, or acetylamino-substituted-C.sub.1-4 alkyl ester of said acid.

12. The method of claim 11 wherein R' is CH.sub.3.

13. The method of claim 11 wherein R is 1,1-dimethylpropyl.

14. The method of claim 12 wherein R is 1,1-dimethylpropyl.

15. The method of claim 11 wherein none of X, Y or Z is a double bond.

16. A compound of the formula: ##STR74## wherein R' is H or CH.sub.3 ; R is

(1) C.sub.3-10 cycloalkyl,

(2) C.sub.2-10 alkenyl,

(3) C.sub.1-10 CF.sub.3 -substituted alkyl,

(4) phenyl,

(5) halophenyl,

(6) phenyl-C.sub.1-3 alkyl

(7) substituted phenyl-C.sub.1-3 alkyl in which the substituent is halo, C.sub.1-3 alkyl or C.sub.1-3 alkoxy;

the dotted lines at X, Y and Z represent possible double bonds, said double bonds, when any are present, being either X and Z in combination or X, Y or Z alone or the corresponding dihydroxy acid of the formula: ##STR75## or a pharmaceutically acceptable salt of said acid, a C.sub.1-4 alkyl ester of said acid or a phenyl-, dimethylamino-, or acetylamino-substituted-C.sub.1-4 alkyl ester of said acid.

17. A pharmaceutical antihypercholesterolemic composition comprising a pharmaceutical carrier and an antihypercholesterolemic effective amount of a compound of structural formula: ##STR76## in which R' is H or CH.sub.3 ; R is

(1) C.sub.3-10 cycloalkyl,

(2) C.sub.2-10 alkenyl,

(3) C.sub.1-10 CF.sub.3 -substituted alkyl,

(4) phenyl,

(5) halophenyl,

(6) phenyl-C.sub.1-3 alkyl,

(7) substituted phenyl-C.sub.1-3 alkyl in which the substituent is halo, C.sub.1-3 alkyl or C.sub.1-3 alkoxy;

the dotted lines at X, Y and Z represent possible double bonds, said double bonds, when any are present, being either X and Z in combination or X, Y or Z alone; or

the corresponding dihydroxy acid of the formula: ##STR77## or a pharmaceutically acceptable salt of said acid, a C.sub.1-4 alkyl ester of said acid or a phenyl-, dimethylamino-, or acetylamino-substituted-C.sub.1-4 alkyl ester of said acid.

18. A method of treating hypercholesterolemia in a patient in need of such treatment which comprises administration of an antihypercholesterolemic effective amount of a compound of structural formula: ##STR78## in which R' is H or CH.sub.3 ; R is

(1) C.sub.3-10 cycloalkyl,

(2) C.sub.2-10 alkenyl,

(3) C.sub.1-10 CF.sub.3 -substituted alkyl,

(4) phenyl,

(5) halophenyl,

(6) phenyl-C.sub.1-3 alkyl,

(7) substituted phenyl-C.sub.1-3 alkyl in which the substituent is halo, C.sub.1-3 alkyl or C.sub.1-3 alkoxy;

the dotted lines at X, Y and Z represent possible double bonds, said double bonds, when any are present, being either X and Z in combination or X, Y or Z alone; or

the corresponding dihydroxy acid of the formula: ##STR79## or a pharmaceutically acceptable salt of said acid, a C.sub.1-4 alkyl ester of said acid or a phenyl-, dimethylamino-, or acetylamino-substituted C.sub.1-4 alkyl ester of said acid.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Queensland Health
Chubb
Merck
US Army
Fuji
UBS
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot